Target intelligence / Profile preview

Bovine pathogenic Clostridium surface receptors (None)

Target
None
Molecular classification
Receptor, Ion channel, Cell adhesion molecule, Transporter, Other
01

Overview

Bovine pathogenic Clostridium surface receptors refer to a heterogeneous group of host cell membrane proteins and molecules that serve as the primary binding sites for toxins and surface-associated virulence factors produced by pathogenic Clostridium species in cattle. These species, including Clostridium perfringens, Clostridium chauvoei, and Clostridium septicum, cause severe and often fatal diseases such as blackleg, enterotoxemia, and malignant edema. The receptors are molecularly diverse and include claudins (targeted by C. perfringens enterotoxin), the myelin and lymphocyte (MAL) protein (targeted by epsilon toxin), P2X7 purinergic receptors (targeted by beta toxin), and Toll-like receptors such as TLR5 (which recognizes flagellin). Binding to these receptors is a prerequisite for toxin-mediated pore formation, enzymatic degradation of the cell membrane, or the induction of pro-inflammatory signaling, all of which contribute to rapid tissue necrosis and systemic toxemia (Source: 10.2.2, 10.2.3, 10.2.4). In the livestock industry, these receptors are not typically targeted by direct pharmacological antagonists. Instead, the therapeutic and preventive focus is on neutralizing the bacterial ligands (toxins and surface antigens) before they can engage these receptors. This is achieved through the administration of multivalent bacterin-toxoid vaccines, which induce protective humoral immunity, and the use of specific antitoxins for passive immunization in acute cases (Source: 8.1.5, 10.1.3). While the term is often used collectively to describe the host-pathogen interface, it may also refer to bacterial surface-associated proteins like flagellin and S-layer proteins, which are the primary targets for the development of recombinant vaccines (Source: 10.1.1, 10.2.1).

Other names
Host receptors for clostridial toxinsClostridial toxin receptorsBovine clostridial receptorsClostridial surface-associated proteins
02

Mechanism of action

Vaccines and antitoxins induce or provide antibodies that neutralize bacterial toxins and opsonize vegetative cells, thereby preventing their interaction with host surface receptors; antibiotics inhibit bacterial growth to reduce toxin production.

03

Biological functions

Signal transductionCell adhesionMembrane permeabilityImmune responseCell deathIon transport
04

Disease associations

InfectionOther
05

Safety considerations

Rapid disease progression leading to sudden deathHigh case fatality rate (often approaching 100%)Limited therapeutic window once clinical signs appearPotential for vaccine-induced injection site reactions or anaphylaxis
06

Interacting drugs

Clostridial bacterin-toxoid vaccines (e.g., Covexin 8, Tasvax 8, UltraChoice 8)

3 more in the full profile.

07

Biomarkers

Clostridial toxins (e.g., Alpha, Beta, Epsilon, Iota) in intestinal contentsSpecific antibody titers against Clostridium antigens (ELISA)PCR detection of toxin genes in tissue or fecesPresence of Clostridium spores or vegetative cells in necrotic tissue

Beyond the preview

Go deeper on Bovine pathogenic Clostridium surface receptors (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bovine pathogenic Clostridium surface receptors (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call